MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PDSB has $24,663,026 in assets. $20,770,383 in debts. $21,660,496 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
225.55%
Quick Ratio
225.55%
Cash Ratio
213.47%
Debt to Asset Ratio
84.22%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses
    • Prepaid expenses and other asset...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Note payable, net of debt discou...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
21,660,496 26,711,969 26,198,652 31,873,495
Prepaid expenses and other assets
1,225,381 1,542,116 1,694,258 1,774,550
Total current assets
22,885,877 28,254,085 27,892,910 33,648,045
Prepaid expenses
1,548,580 1,996,300 6,554,064 6,554,064
Property and equipment
-295,911 --
Less accumulated depreciation
-175,727 --
Property and equipment, net
114,725 120,184 125,643 131,102
Financing lease right-to-use assets
113,844 123,514 133,184 142,854
Total assets
24,663,026 30,494,083 34,705,801 40,476,065
Accounts payable
3,650,352 3,574,448 5,180,928 4,497,434
Accrued expenses
1,258,817 742,227 2,104,390 1,482,081
Current portion of notes payable
5,206,574 5,130,372 6,000,000 5,500,000
Financing lease obligation-short term
30,982 36,167 44,142 51,937
Total current liabilities
10,146,725 9,483,214 13,329,460 11,531,452
Note payable, net of debt discount
10,605,985 11,733,350 11,889,314 12,943,656
Financing lease obligation-long term
17,673 25,686 33,517 41,173
Total liabilities
20,770,383 21,242,250 25,252,291 24,516,281
Common stock, 0.00033 par value, 150,000,000 shares authorized at march 31, 2026 and december 31, 2025, respectively 55,815,653 and 54,878,233 issued and outstanding at march 31, 2026 and december 31, 2025, respectively
18,420 18,111 15,744 15,390
Additional paid-in capital
227,829,783 225,840,226 218,481,351 215,978,568
Accumulated deficit
-223,955,560 -216,606,504 -209,043,585 -200,034,174
Total stockholders' equity
3,892,643 9,251,833 9,453,510 15,959,784
Total liabilities and stockholders' equity
24,663,026 30,494,083 34,705,801 40,476,065
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$21,660,496 Prepaid expenses andother assets$1,225,381 Total current assets$22,885,877 Prepaid expenses$1,548,580 Property and equipment,net$114,725 Financing leaseright-to-use assets$113,844 Total assets$24,663,026 Total liabilities andstockholders' equity$24,663,026 Total liabilities$20,770,383 Total stockholders'equity$3,892,643 Accumulated deficit-$223,955,560 Note payable, net ofdebt discount$10,605,985 Total currentliabilities$10,146,725 Financing leaseobligation-long term$17,673 Additional paid-in capital$227,829,783 Common stock, 0.00033par value,...$18,420 Current portion of notespayable$5,206,574 Accounts payable$3,650,352 Accrued expenses$1,258,817 Financing leaseobligation-short term$30,982

PDS Biotechnology Corp (PDSB)

PDS Biotechnology Corp (PDSB)